levamlodipine maleate

levamlodipine maleate (CONJUPRI) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

CONJUPRI is a marketed brand name for levamlodipine maleate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

levamlodipine maleate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.